Brawn Biotech Ltd.

BSE: 530207 | GSM

Download real time

16.19 -0.80 (-4.71%)

Near 52W Low of ₹15.50

563 BSE Volume

High volume today

BSE 21 Mar, 2025 3:31 PM (IST)

4.9

Market Cap

Low in industry

-0.1

Beta 1Year

Very Low volatility

Brawn Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Brawn Biotech Ltd. on BSE

Search Inside the pdf :

Brawn Biotech Ltd.

14 Feb 2025

16.19

-4.71%

Corp. Note

BRAWN BIOTECH LTD. - 530207 - Integrated Filing (Financial)

BSE India

UFR in integrated filing is attached.

Brawn Biotech Ltd.

14 Feb 2025

16.19

-4.71%

Company Update

BRAWN BIOTECH LTD. - 530207 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation of publication of unaudited financial results under regulation 47.

Brawn Biotech Ltd.

12 Feb 2025

16.19

-4.71%

Result

BRAWN BIOTECH LTD. - 530207 - UNAUDITED FINANCILA RESULTS FOR QUARTER ENDED DEC 2024

BSE India

SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR QUARTER ENDED DEC 2024

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	3.85	3.30	2.85	16.7%	35.1%
Operating Profit Qtr	-0.40	-0.32	-0.58	-25.0%	31.0%
Net Profit Qtr	-0.43	-0.34	-0.61	-26.5%	29.5%
Earning Per Share Adjusted latest Qtr	-1.44	-1.15	-2.02	-25.2%	28.7%

* Standalone data

Detailed Results

Brawn Biotech Ltd.

12 Feb 2025

16.19

-4.71%

Board Meeting

BRAWN BIOTECH LTD. - 530207 - Board Meeting Outcome for Outcome Of The Board Meeting Of …

BSE India

Outcome of the Board Meeting of the Company held on 12th February, 2025, and submissions of Un-Audited Financial Results for the Quarter 31.12.2024 AS PER Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (SEBI Listing regulations).

Brawn Biotech Ltd.

04 Feb 2025

16.19

-4.71%

Board Meeting

BRAWN BIOTECH LTD. - 530207 - Board Meeting Intimation for The Quarter Ended 31 December 2024

BSE India

BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve unaudited financial results for the quarter/nine months ended 31/12/2024.

Brawn Biotech Ltd.

10 Jan 2025

16.19

-4.71%

Company Update

BRAWN BIOTECH LTD. - 530207 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

CERTIFICATE UNDER REGULATION 74(5) OF THE SEBI (DEPOSITORIES AND PARTICIPENTS) REGULATIONS, 2018 FOR THE QUARTER ENDED 31 DECEMBER 2024

Brawn Biotech Ltd.

30 Dec 2024

16.19

-4.71%

SAST

BRAWN BIOTECH LTD. - 530207 - Closure of Trading Window

BSE India

Intimation of Closure of Trading Window for quarter ended December 2024

Brawn Biotech Ltd.

22 Nov 2024

16.19

-4.71%

Company Update

BRAWN BIOTECH LTD. - 530207 - Disclosure Of Non-Applicability For Filing Of Related Party Transaction

BSE India

Disclosure of Non-applicability for filing of Related Party Transaction under Regulation 23(9).

Brawn Biotech Ltd.

16 Nov 2024

16.19

-4.71%

Company Update

BRAWN BIOTECH LTD. - 530207 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of UFR for quarter/half year ended 30/09/2024

Brawn Biotech Ltd.

16 Nov 2024

16.19

-4.71%

Company Update

BRAWN BIOTECH LTD. - 530207 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of UFR for quarter/half year ended 30/09/2024

No results found

Is Brawn Biotech Ltd. worth buying?

10 Votes:

Buy 100.0%